Praxsyn Corp. Bundle
What is Praxsyn Corp.'s Journey?
Praxsyn Corporation, formerly The PAWS Pet Company, Inc., began in 2005 as a pet airline. A significant shift occurred in March 2014 through a reverse merger with Mesa Pharmacy, rebranding the company as Praxsyn Corporation and marking its entry into the healthcare sector.
Headquartered in Las Vegas, Nevada, Praxsyn initially focused on providing specialized compounded medications, particularly for chronic pain management within California's workers' compensation system.
What is the brief history of Praxsyn Corp. Company?
Founded in 2005 as The PAWS Pet Company, Inc., Praxsyn Corporation embarked on an unconventional path, starting as a pet airline. The company's trajectory dramatically shifted in March 2014 when it merged with Mesa Pharmacy, subsequently rebranding as Praxsyn Corporation and pivoting to the healthcare industry. This strategic move aimed to leverage opportunities in medical services, with an initial focus on compounded medications for chronic pain management. Understanding the competitive landscape is crucial, and a Praxsyn Corp. Porter's Five Forces Analysis can offer valuable insights into its market position.
What is the Praxsyn Corp. Founding Story?
The Praxsyn Corp history began on June 5, 2005, as The PAWS Pet Company, Inc., founded by Wiesel Daniel and Alysa Binder. Initially based in San Jose, California, this early venture focused on operating a specialized airline for pet transportation, with Daniel Wiesel serving as CEO.
The Founding Story of Praxsyn Corporation
Praxsyn Corporation's journey started as The PAWS Pet Company, Inc. on June 5, 2005, in San Jose, California. The founders, Wiesel Daniel and Alysa Binder, identified a market gap for humane pet air travel services.
- Founded as The PAWS Pet Company, Inc. on June 5, 2005.
- Initial focus on specialized pet air transportation.
- Founders: Wiesel Daniel and Alysa Binder.
- Early headquarters: San Jose, California.
A pivotal moment in the Praxsyn Company timeline overview occurred on October 29, 2013, with a reverse merger with Mesa Pharmacy, Inc. This strategic move signaled a significant departure from its original pet transport business. Subsequently, on March 10, 2014, the company officially rebranded as Praxsyn Corporation, marking its complete transition into the healthcare sector.
Following the name change, Praxsyn Corporation concentrated on acquiring and managing healthcare assets. Its initial core offering was through Mesa Pharmacy, a subsidiary that specialized in providing custom-compounded non-narcotic, transdermal topical pain medications. These were primarily supplied to medical practitioners serving patients within the California workers' compensation system, a growing and complex area of healthcare. This strategic pivot reflects the company's adaptation to evolving market demands and opportunities within the healthcare industry, laying the groundwork for its future Revenue Streams & Business Model of Praxsyn Corp.
Praxsyn Corp. SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of Praxsyn Corp.?
Following its rebranding to Praxsyn Corporation in March 2014, the company's initial growth was closely tied to its Mesa Pharmacy subsidiary. The focus was on compounded medications for pain management, erectile dysfunction, and metabolic therapies, primarily marketed to industrial health physicians and medical clinics within the California workers' compensation system.
Early Focus on Compounded Medications
Praxsyn Corporation's early strategy centered on offering transdermal creams and ointments as alternatives to traditional oral pain medications. These compounded products targeted patients covered by California's workers' compensation system.
Expansion of Services
By April 2014, the company announced plans to broaden its offerings to include a Point of Care/In-Office Dispensing Program and In-Office Toxicology Testing. This move aimed to empower healthcare providers with diverse delivery systems.
Market Positioning and Challenges
The competitive landscape for compounded pharmaceuticals is populated by numerous specialized pharmacies. Market reception during this initial phase would have been influenced by the efficacy and cost-effectiveness of Praxsyn's compounded products within the workers' compensation framework.
Financial Snapshot and Strategic Shift
By 2015, public records indicated a trailing twelve-month revenue of $63.5 million for the company. Subsequently, the company transitioned towards a holding company model, focusing on acquiring and managing healthcare assets, though detailed recent growth metrics for this evolution are not widely publicized, as noted in the Brief History of Praxsyn Corp.
Praxsyn Corp. PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What are the key Milestones in Praxsyn Corp. history?
The Praxsyn Corp history is characterized by a significant strategic shift rather than continuous product innovation, alongside persistent operational and legal hurdles. A pivotal moment was the acquisition of Mesa Pharmacy, Inc. in late 2013, which transitioned the former PAWS Pet Company into a healthcare-focused entity, leading to the rebranding as Praxsyn Corporation in March 2014. This move allowed entry into the specialized market of compounded non-narcotic pain medications, targeting a specific segment within California's workers' compensation system.
| Year | Milestone |
|---|---|
| 2013 | Acquisition of Mesa Pharmacy, Inc., marking a strategic pivot to the healthcare sector. |
| 2014 | Rebranded as Praxsyn Corporation, solidifying its new identity in the healthcare market. |
| 2023 | Leadership transition with Sean Daly assuming CEO and sole board member roles. |
The company's innovation efforts have been largely centered on adapting its business model to the specialized niche of compounded pain medications. This focus allowed Praxsyn to address specific needs within the California workers' compensation system.
Entry into Compounded Pain Medications
Praxsyn Corporation entered the specialized market of compounded non-narcotic pain medications following its acquisition of Mesa Pharmacy, Inc. This strategic move allowed the company to cater to a specific niche within the California workers' compensation system.
Praxsyn Corporation has encountered substantial challenges, including ongoing litigation related to its subsidiary, Mesa Pharmacy, Inc., before the California Workers' Compensation Appeals Board. These legal disputes involve allegations of 'de facto control' by an individual with a prior conviction and findings that Mesa Pharmacy acted as the 'alter ego' of Praxsyn Corporation, impacting its operational independence and financial health. A significant and persistent issue has been the company's failure to maintain current financial filings on the OTC Markets, a situation attributed to 'disruptions to the expected timeline [...] beyond the control of the Company'. This regulatory non-compliance has diminished market visibility and investor confidence, as evidenced by its stock price of $0.000001 USD as of recent reporting. The company is also actively pursuing the collection of up to $30,000 in unclaimed property for Mesa Pharmacy from the State of California, indicating efforts to improve its financial standing. These difficulties highlight the complexities smaller public companies face in navigating regulatory environments and litigation, shifting the focus towards compliance and financial stability over outward innovation. Understanding these dynamics is crucial when examining the Competitors Landscape of Praxsyn Corp.
Ongoing Litigation and Legal Findings
The company has been involved in complex legal battles concerning its subsidiary, Mesa Pharmacy, Inc. These cases have included findings that Mesa Pharmacy was the 'alter ego' of Praxsyn Corporation.
Failure to Maintain Financial Filings
Praxsyn Corporation has faced persistent challenges in remaining current with its financial filings on the OTC Markets. This has been attributed to disruptions beyond the company's control, impacting investor confidence and market visibility.
Leadership Transition Amidst Difficulties
In July 2023, the company experienced a leadership change with Daniel Oswald resigning as CEO and Sean Daly taking over these roles. This transition signals an attempt to restructure and address the ongoing challenges.
Pursuit of Unclaimed Property
Efforts to improve the company's financial position include the pursuit of up to $30,000 in unclaimed property for Mesa Pharmacy from the State of California. This action is part of the company's strategy to address its financial situation.
Praxsyn Corp. Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What is the Timeline of Key Events for Praxsyn Corp.?
The Praxsyn Corp history is marked by significant shifts in its business focus and operational challenges. Initially founded as a pet airline, the company underwent a pivotal transformation through a reverse merger, ultimately pivoting to the healthcare sector.
| Year | Key Event |
|---|---|
| 2005 | The PAWS Pet Company, Inc. was founded, beginning operations as a pet airline. |
| October 29, 2013 | The PAWS Pet Company completed a reverse merger with Mesa Pharmacy, Inc. |
| March 2014 | The company officially changed its name to Praxsyn Corporation, signaling a strategic shift towards healthcare services. |
| April 2014 | Praxsyn announced its intentions to launch a Point of Care/In-Office Dispensing Program and In-Office Toxicology Testing initiatives. |
| September 30, 2015 | The company reported trailing twelve-month revenue of $63.5 million, which remains the last publicly updated revenue figure. |
| 2019-2020 | Praxsyn Corporation began issuing 'Notification of Late Filing' on OTC Markets, indicating reporting delays. |
| April 21, 2020 | The company's stock, PXYN, reached its lowest point at $0.000001 USD. |
| April 2021 | Praxsyn's subsidiary, Mesa Pharmacy, Inc., filed a Petition for Reconsideration concerning ongoing litigation in California before the Workers' Compensation Appeals Board. |
| February 2022 | The company stated its ongoing efforts to complete missing filings and become current with its reporting obligations. |
| July 25, 2022 | Praxsyn announced its pursuit of up to $30,000 in unclaimed property from the State of California for Mesa Pharmacy. |
| July 12, 2023 | Daniel Oswald resigned as CEO, and Sean Daly was appointed as the new CEO and sole board member. |
| October 3, 2023 | WorkCompAcademy published findings related to 'de facto control' and 'alter ego' status concerning Mesa Pharmacy and Praxsyn Corporation. |
Resolving Compliance and Legal Hurdles
Praxsyn Corporation's future hinges on addressing its outstanding regulatory and legal issues. The company has indicated plans to explore financing and business development opportunities once its filings are current.
Strategic Focus on Healthcare Sector
The company's stated vision involves empowering healthcare, but current efforts are concentrated on stabilizing its operational and financial foundations. This includes resolving litigation and updating financial reporting.
Industry Trends and Company Position
The broader healthcare industry continues to attract investment in areas like revenue cycle management. However, Praxsyn's ability to leverage these trends is currently limited by its foundational compliance and legal challenges.
Leadership and Future Direction
With new leadership in place as of July 2023, the company's forward-looking statements emphasize achieving current reporting status and resolving the Mesa Pharmacy litigation. Understanding the Target Market of Praxsyn Corp. is key to its future strategy.
Praxsyn Corp. Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Competitive Landscape of Praxsyn Corp. Company?
- What is Growth Strategy and Future Prospects of Praxsyn Corp. Company?
- How Does Praxsyn Corp. Company Work?
- What is Sales and Marketing Strategy of Praxsyn Corp. Company?
- What are Mission Vision & Core Values of Praxsyn Corp. Company?
- Who Owns Praxsyn Corp. Company?
- What is Customer Demographics and Target Market of Praxsyn Corp. Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.